{{Drugbox
| verifiedrevid = 461094015
| IUPAC_name = (''RS'')-3-amino-9,13b-dihydro-1''H''-dibenz(c,f)imidazo(1,5-a)azepine
| image = Epinastine.svg
| image2 = Epinastine-3D-balls.png
<!-- Clinical data -->
| tradename =  Alesion, Elestat, Purivist, Relestat
| Drugs.com = {{drugs.com|monograph|epinastine-hydrochloride}}
| MedlinePlus = a604011
| pregnancy_category = C
| legal_status =  
| routes_of_administration = [[Eye drops]]
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound = 64%
| metabolism =  
| elimination_half-life = 12 hours
<!-- Identifiers -->
| IUPHAR_ligand = 7176
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 80012-43-7
| ATC_prefix = R06
| ATC_suffix = AX24
| ATC_supplemental =  {{ATC|S01|GX10}}
| PubChem = 3241
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB00751
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 3128
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = Q13WX941EF
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07900
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 51032
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 1106
<!-- Chemical data -->
| C=16 | H=15 | N=3
| molecular_weight = 249.311 g/mol
| smiles = N\4=C(\N3c1c(cccc1)Cc2c(cccc2)C3C/4)N
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C16H15N3/c17-16-18-10-15-13-7-3-1-5-11(13)9-12-6-2-4-8-14(12)19(15)16/h1-8,15H,9-10H2,(H2,17,18)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = WHWZLSFABNNENI-UHFFFAOYSA-N
}}

'''Epinastine''' (brand names '''Alesion''', '''Elestat''', '''Purivist''', '''Relestat''') is a second-generation [[antihistamine]] and [[mast cell]] stabilizer that is used in [[eye drop]]s to treat [[allergic conjunctivitis]]. It is produced by [[Allergan]] and marketed by Inspire in the United States.<ref>{{cite journal|pmid=19630694|year=2009|last1=Pradhan|first1=S|last2=Abhishek|first2=K|last3=Mah|first3=F|title=Epinastine: topical ophthalmic second generation antihistamine without significant systemic side effects|volume=5|issue=9|pages=1135–40|doi=10.1517/17425250903117284|journal=Expert opinion on drug metabolism & toxicology}}</ref> It is highly [[binding selectivity|selective]] for the [[H1 receptor|H<sub>1</sub> receptor]] and does not cross the [[blood-brain-barrier]].<ref name="pmid1972625">{{cite journal |vauthors=Walther G, Daniel H, Bechtel WD, Brandt K | title = New tetracyclic guanidine derivatives with H1-antihistaminic properties. Chemistry of epinastine | journal = Arzneimittel-Forschung | volume = 40 | issue = 4 | pages = 440–6 |date=April 1990 | pmid = 1972625 | doi = | url = }}</ref>

== References ==
{{Reflist}}

== External links ==
* [http://www.elestat.com  Official U.S. website of Elestat]

{{Antihistamines}}
{{Histamine receptor modulators}}
{{Tricyclics}}

[[Category:Azepanes]]
[[Category:H1 receptor antagonists]]
[[Category:Guanidines]]
[[Category:Mast cell stabilizers]]
[[Category:Peripherally selective drugs]]

{{respiratory-system-drug-stub}}